CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,047,000 | +57.8% | 119,720 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $2,565,000 | -19.9% | 109,689 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $3,201,000 | +49.4% | 111,130 | +5.0% | 0.00% | 0.0% |
| Q3 2020 | $2,143,000 | -26.6% | 105,806 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $2,919,000 | +51.9% | 97,145 | +58.8% | 0.00% | 0.0% |
| Q1 2020 | $1,922,000 | -20.2% | 61,165 | +19.7% | 0.00% | 0.0% |
| Q4 2019 | $2,408,000 | +1025.2% | 51,116 | +54.3% | 0.00% | – |
| Q3 2019 | $214,000 | -52.0% | 33,131 | -8.8% | 0.00% | – |
| Q2 2019 | $446,000 | -13.7% | 36,330 | -4.9% | 0.00% | – |
| Q1 2019 | $517,000 | – | 38,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |